Microorganisms with enhanced l-alanine productivity and method for producing l-alanine using same

MYPI2025002491A0Undetermined Publication Date: 2024-06-30CJ CHEILJEDANG CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002491
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-12-30
Filing Date
2023-04-07
Publication Date
2024-06-30

AI Technical Summary

Technical Problem

Current industrial production of L-alanine relies heavily on chemical synthesis and enzymatic conversion from petroleum-derived substrates, resulting in high costs and low yields, while microbial fermentation offers a promising alternative but is limited by the low productivity of naturally derived strains.

Method used

Development of mutant strains of Corynebacterium glutamicum, such as CJ0230, CJ2011, CJ2015, CJ2057, and CJ2064, which are produced through radiation mutagenesis, exhibiting improved L-alanine production capabilities, with strains capable of producing 1.5 to 3 times more L-alanine than the parent strain.

Benefits of technology

The mutant strains significantly enhance L-alanine productivity, achieving yields of 50% to 100% more than the parent strain, thereby improving the efficiency and cost-effectiveness of L-alanine production through microbial fermentation.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to a mutant strain of Corynebacterium, a method for producing the strain, and a method for producing L-alanine using the strain, the mutant strain having improved L-alanine productivity due to radiation-induced mutations compared to the parent strain. Said mutant strain of Corynebacterium has improved L-alanine productivity compared to the parent strain, and, as such, use of the strain allows highly efficient and high-yield production of L-alanine.
Need to check novelty before this filing date? Find Prior Art

Description

Microorganisms with enhanced L-alanine production capacity and methods for producing L-alanine using the same

[0001] Cross-citation with related application(s)

[0002] This application claims the benefit of priority to Korean Patent Application No. 10-2022-0190975, filed December 30, 2022, the entire contents of which are incorporated herein by reference.

[0003] The present invention relates to a microorganism having improved L-alanine production ability and a method for producing L-alanine using the same.

[0004] L-alanine is an important amino acid with wide applications in fields such as chemistry, food, and medicine. As a sweet amino acid, it is particularly used in the food industry as a flavor enhancer and nutritional supplement. As of 2020, the global alanine market was valued at over USD 250 million, with an annual production of approximately 500 tons (The Expresswire, 2020; Wendisch, 2014).

[0005] L-alanine is typically produced through chemical synthesis or enzymatic conversion. Chemical synthesis is achieved using a modified version of the Strecker synthesis or Bucherer-Bergs method (Legnani et al., 2021), while enzymatic conversion is achieved from L-aspartic acid with ammonium fumarate (Takamatsu et al., 1982). Most industrial production is achieved through enzymatic conversion processes, but the substrate, L-aspartic acid, is produced from petroleum. The production of fumaric acid also relies on petroleum, making it costly and reducing yields when replaced. Therefore, microbial fermentation offers an interesting alternative by providing an abundant carbon source at low cost. Naturally, microorganisms produce L-alanine using aminotransferase or alanine dehydrogenase. However, low productivity limits the production of L-alanine using naturally occurring strains.

[0006] Against this backdrop, the inventors of the present invention have made diligent efforts to develop a microorganism producing L-alanine with a higher yield than conventional strains, and have discovered that a mutant strain obtained using Corynebacterium produces L-alanine with a high yield, thereby completing the present invention.

[0007] One example of the present invention provides a mutant strain of the genus Corynebacterium obtained by mutating the parent strain Corynebacterium glutamicum ATCC13869, which has improved L-alanine production ability compared to the parent strain.

[0008] Another example of the present invention is

[0009] 1) A step of irradiating the parent strain, Corynebacterium glutamicum ATCC13869, to induce mutation; and

[0010] 2) A method for producing a mutant strain having improved L-alanine production ability compared to a parent strain is provided, comprising a step of culturing the mutated strain of step 1) in a medium and selecting a mutant strain having improved L-alanine production ability.

[0011] Another example of the present invention provides a composition for producing L-alanine comprising a microorganism having improved L-alanine production ability.

[0012] Another example of the present invention provides a method for producing L-alanine, comprising a step of culturing a microorganism with improved L-alanine production ability in a medium.

[0013] Another example of the present invention provides a use for producing L-alanine by a microorganism having improved L-alanine production ability.

[0014]

[0015] This is specifically explained as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. That is, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below. Furthermore, those skilled in the art will recognize or be able to identify numerous equivalents to the specific embodiments of this application described in this application using only routine experimentation. Furthermore, such equivalents are intended to be encompassed by this application.

[0016]

[0017] The present invention provides a microorganism having improved L-alanine production ability.

[0018] In the present invention, screening was conducted to discover mutant strains that produce high levels of L-alanine. As a result, five mutant strains produced by irradiating the Corynebacterium glutamicum ATCC13869 strain were confirmed to have improved L-alanine productivity compared to the ATCC13869 strain.

[0019] The present invention provides a mutant strain of the genus Corynebacterium obtained by mutating the parent strain Corynebacterium glutamicum ATCC13869, which has improved L-alanine production ability compared to the parent strain.

[0020] The above microorganism may be a mutant strain of Corynebacterium glutamicum.

[0021] The above Corynebacterium glutamicum mutant strain is any one strain selected from the group consisting of Corynebacterium glutamicum CJ0230 strain (accession number KCCM13305P), Corynebacterium glutamicum CJ2011 strain (accession number KCCM13306P), Corynebacterium glutamicum CJ2015 strain (accession number KCCM13307P), Corynebacterium glutamicum CJ2057 strain (accession number KCCM13308P), and Corynebacterium glutamicum CJ2064 strain (accession number KCCM13309P). Can be.

[0022] In this specification, the term “L-alanine” refers to an L-amino acid, which is one of the essential amino acids and has the chemical formula “C3H7NO2”.

[0023] In this specification, the term “productivity” means the ability to produce L-alanine, and may be used interchangeably with “productivity,” and can be confirmed by measuring the concentration of L-alanine contained in the culture solution after culturing a strain that produces L-alanine.

[0024] The above mutation method can be performed by various means known in the art, and one of physical or chemical mutagenesis methods can be used. For example, a method of irradiating gamma rays or ultraviolet rays can be used as a physical mutagenesis method suitable for the present invention, but is not limited thereto. In addition, N-Methyl-N'-nitro-N-nitrosoguanidine (NTG), diepoxybutane, ethyl methane sulfonate, mustard compounds, hydrazine, and nitrous acid can be used as a chemical mutagenesis method, but is not limited thereto.

[0025] The mutation for producing the above mutant strain may be by a method of irradiating it.

[0026] The radiation for inducing the above mutation may be gamma rays or ultraviolet rays, and preferably gamma rays.

[0027] The radiation may be at a dose of 3.0 kGy to 5.0 kGy, 3.1 kGy to 4.9 kGy, 3.2 kGy to 4.8 kGy, 3.3 kGy to 4.7 kGy, 3.4 kGy to 4.6 kGy, 3.5 kGy to 4.5 kGy, 3.6 kGy to 4.4 kGy, 3.7 kGy to 4.3 kGy, 3.8 kGy to 4.2 kGy, 3.9 kGy to 4.1 kGy, preferably 4.0 kGy, but is not limited thereto.

[0028] The above mutant strain may produce 1.5 times more L-alanine than the parent strain, 1.6 times more, 1.7 times more, or 1.5 to 3 times more.

[0029] The above mutant strain may have an L-alanine production ability that is improved by 1.5 times or more, by 1.6 times or more, by 1.7 times or more, or by 1.5 to 3 times more than the parent strain.

[0030] The above mutant strain may have an increased L-alanine productivity of 50% or more, 60% or more, 70% or more, 75% or more, 50% to 100%, 60% to 100%, 70% to 100%, 50% to 80%, 60% to 80%, 70% to 80%, or 75% compared to the parent strain.

[0031] The parent strain may be, but is not limited to, Corynebacterium glutamicum ATCC13869.

[0032]

[0033] In addition, the present invention

[0034] 1) A step of irradiating the parent strain, Corynebacterium glutamicum ATCC13869, to induce mutation; and

[0035] 2) A method for producing a mutant strain of the genus Corynebacterium having improved L-alanine production ability compared to the parent strain is provided, comprising a step of culturing the mutant strain of step 1) in a medium and selecting a mutant strain having improved L-alanine production ability.

[0036] The above radiation may be gamma rays or ultraviolet rays, and preferably gamma rays.

[0037] The radiation may be at a dose of 3.0 kGy to 5.0 kGy, 3.1 kGy to 4.9 kGy, 3.2 kGy to 4.8 kGy, 3.3 kGy to 4.7 kGy, 3.4 kGy to 4.6 kGy, 3.5 kGy to 4.5 kGy, 3.6 kGy to 4.4 kGy, 3.7 kGy to 4.3 kGy, 3.8 kGy to 4.2 kGy, 3.9 kGy to 4.1 kGy, preferably 4.0 kGy, but is not limited thereto.

[0038] During mutation induction, the parent strain is affected by a mutagen under conditions that leave a certain size of viable cells. These conditions vary depending on the type of mutagen and depend on the amount of mutations that the mutagen induces in the viable cells with a certain kill rate (viability). For example, in the case of gamma rays, the kill rate can leave approximately 0.00001% to 20% of the starting population, in the case of NTG, the kill rate can leave approximately 10% to 50% of the starting population, and in the case of nitrite, the mutation generation can leave 0.01% to 0.1% of the starting population, but is not limited thereto.

[0039]

[0040] In addition, the present invention provides a composition for producing L-alanine, which comprises a mutant strain of the genus Corynebacterium obtained by mutating the parent strain, Corynebacterium glutamicum ATCC13869, and having improved L-alanine production ability compared to the parent strain.

[0041] The above microorganism may be a mutant strain of Corynebacterium glutamicum.

[0042] The above Corynebacterium glutamicum mutant strain is any one strain selected from the group consisting of Corynebacterium glutamicum CJ0230 strain (accession number KCCM13305P), Corynebacterium glutamicum CJ2011 strain (accession number KCCM13306P), Corynebacterium glutamicum CJ2015 strain (accession number KCCM13307P), Corynebacterium glutamicum CJ2057 strain (accession number KCCM13308P), and Corynebacterium glutamicum CJ2064 strain (accession number KCCM13309P). Can be.

[0043] In one embodiment of the present invention, the mutant strains Corynebacterium glutamicum CJ0230 strain (accession number KCCM13305P), Corynebacterium glutamicum CJ2011 strain (accession number KCCM13306P), Corynebacterium glutamicum CJ2015 strain (accession number KCCM13307P), Corynebacterium glutamicum CJ2057 strain (accession number KCCM13308P), and Corynebacterium glutamicum CJ2064 strain (accession number It was confirmed that the mutant strain (KCCM13309P) produces L-alanine at a high concentration. Therefore, L-alanine can be produced at a high concentration using a composition including the mutant strain.

[0044]

[0045] In addition, the present invention provides a method for producing L-alanine, which comprises the step of culturing a mutant strain of the genus Corynebacterium, which is obtained by mutating the parent strain Corynebacterium glutamicum ATCC13869, and which has improved L-alanine production ability compared to the parent strain, in a medium.

[0046] The method may further include, after the culturing step, a step of recovering L-alanine from the cultured microorganism, the culture, or both.

[0047] The term “cultivation” as used herein refers to growing microorganisms under appropriately artificially controlled environmental conditions. The method for culturing the microorganisms of the present invention can be performed using a culture method for Corynebacterium glutamicum, which is widely known in the art. Specifically, examples of the above-mentioned culture methods include, but are not limited to, batch culture, continuous culture, and fed-batch culture. Various such methods are disclosed, for example, in “Biochemical Engineering” (James M. Lee, Prentice-Hall International Editions, pp. 138-176, 1991).

[0048] The term "culture" as used herein refers to a substance containing a medium in which microorganisms are growing or have completed growth under appropriately artificially controlled environmental conditions. In a narrow sense, the culture does not include grown microorganisms, but in a broader sense, it may include them. The "culture" includes various substances released into the medium by the microorganisms during growth, along with medium components prepared for culturing the microorganisms, and specifically includes the target substance, alanine.

[0049] The culture medium must suitably meet the requirements of the specific strain. Culture media for strains of the genus Corynebacterium are known. For example, the microorganism of the present application can be cultured under aerobic conditions, while controlling temperature, pH, etc., in a conventional medium containing an appropriate carbon source, nitrogen source, amino acid, vitamin, etc. In this case, the carbon source includes carbohydrates such as glucose, fructose, and sucrose, and amino acids such as glutamic acid and cysteine. Specifically, natural organic nutrients such as starch hydrolysate and molasses can be used, and carbohydrates such as glucose, fructose, and sterilized pretreated molasses (i.e., molasses converted to reducing sugar) are preferred. Other appropriate carbon sources can be used in various amounts without limitation, but are not limited thereto. Nitrogen sources include inorganic nitrogen sources such as ammonia; amino acids such as glutamic acid and cysteine; and organic nitrogen sources such as peptone, meat extract, and yeast extract. These nitrogen sources can be used alone or in combination, but are not limited thereto. The media may include, but are not limited to, phosphoric acid, potassium dihydrogen phosphate, or dipotassium hydrogen phosphate or their corresponding sodium-containing salts as the personnel. Inorganic compounds may include, but are not limited to, magnesium sulfate, iron sulfate, manganese sulfate, and calcium chloride, and may also include amino acids, vitamins, and appropriate precursors. These media or precursors may be added to the culture in batch or continuous fashion, but are not limited to these.

[0050] During cultivation, compounds such as potassium hydroxide, ammonia, and phosphoric acid can be appropriately added to the culture to adjust the pH of the culture. Furthermore, foaming agents such as fatty acid polyglycol esters can be used to suppress foaming during cultivation. Furthermore, oxygen or an oxygen-containing gas can be injected into the culture to maintain an aerobic state. The culture temperature ranges from 27°C to 37°C, specifically from 30°C to 33°C. The cultivation period can continue until the desired amount of useful substances is obtained, and is typically 20 to 120 hours.

[0051] The step of recovering the above L-alanine may be to collect the desired L-alanine from a medium, culture solution, or microorganism using a legal method known in the art, depending on the culturing method. For example, the step of recovering may be performed by one or more methods selected from, but not limited to, centrifugation, filtration, anion exchange chromatography, crystallization, HPLC, etc. The method of producing the above L-alanine may additionally include a purification step before, simultaneously with, or after the step of recovering.

[0052]

[0053] The mutant strain of the Corynebacterium genus of the present invention is a microorganism whose L-alanine production ability is improved compared to the parent strain through mutation induction. Therefore, according to the method for producing L-alanine of the present invention using the mutant strain of the Corynebacterium genus, L-alanine can be produced with high efficiency and high yield.

[0054]

[0055] Hereinafter, the present invention will be described in more detail with reference to the following examples. However, these examples are only intended to illustrate the present invention, and the scope of the present invention is not limited by these examples.

[0056]

[0057] Example 1. Selection of mutant strains using artificial mutagenesis.

[0058] 1-1. Establishment of gamma irradiation conditions for obtaining mutant strains with improved L-alanine production.

[0059] To obtain a microbial mutant strain with improved L-alanine production ability, the following method was used to induce microbial mutation.

[0060] Gamma irradiation, a physical method, was applied to induce mutations. High-energy gamma rays emitted from the source Co-60 flow along the chromosome, randomly triggering changes in the base sequence, such as base substitutions, deletions, and insertions. Since the degree of base sequence change is proportional to the intensity of the gamma irradiation, high-level gamma rays induce mutations at a high rate while also increasing the death rate (kill rate) of the strain. In order to sufficiently secure a high-quality, diverse mutant library with a high mutation rate, the gamma irradiation conditions for the Corynebacterial strains used as the target were first established.

[0061] Using a high-level gamma irradiation device from Nordion located at the Advanced Radiation Research Institute of Korea Atomic Energy Research Institute, 30 mL of seed medium culture with an absorbance value of 6.09 at 562 nm was irradiated with gamma rays at intensities of 0, 0.5, 1, 2, 3, 4, 5, 7.5, and 10 kGy / hr for 1 hour, and then 10 kGy / hr was added to the activated medium. 0 , 10 -1 , 10 -2 , 10 -3 , 10 -4 Each 100 ㎕ of the gamma-irradiated solution diluted at a dilution ratio was spread, and the plate medium on which the gamma-irradiated solution was spread was cultured in a 30℃ stationary incubator for 48 hours. The number of individual colonies formed was counted to calculate the death rate (kill rate) for each irradiation condition. The CFU / mL according to the gamma-irradiation conditions of 0, 0.5, 1, 2, 3, 4, 5, 7.5, and 10 kGy / hr were 3.6 X 108 , 6.9 X 10 7 , 9.8 X 10 6 , 2.7 X 10 5 , 2.1 X 10 3 , 3.0 X 10 1 , 0, 0, 0, and the calculated mortality rates were 0%, 81.00467%, 97.31540%, 99.92589%, 99.99942%, 99.99999%, 100%, 100%, and 100%, respectively. Considering that all were killed and the colony could not be secured under the gamma-ray irradiation condition of 5 kGy / hr intensity, the gamma-ray irradiation condition was established as 4 kGy / hr intensity to secure a high-quality mutant library with high mutation diversity through Corynebacterial strain-based gamma-ray irradiation.

[0062]

[0063] 1-2. Selection of mutant strains with improved L-alanine production

[0064] To obtain a microorganism with high L-alanine production capacity, a mutant library based on gamma irradiation was constructed targeting Corynebacterium glutamicum ATCC13869 strain, and high L-alanine production mutants were screened. For gamma irradiation of ATCC13869 strain, a 500 mL flask containing 50 mL of seed medium was cultured in a shaking incubator at 30°C for 24 hours to obtain a culture solution with an absorbance value of 7.84 at 562 nm, which was then diluted using the seed medium to obtain an absorbance value of 6.10 at 562 nm. Using a high-level gamma irradiation device at the Advanced Radiation Research Institute of the Korea Atomic Energy Research Institute, 30 mL of the diluted solution was irradiated with 4 kGy / hr of gamma rays for 1 hour, and then 100 ㎕ of the irradiation solution was spread on each of 100 activated media of 90 X 15 mm petri dishes. Then, the petri dishes were cultured in a static incubator at 30℃ for 48 hours to obtain a total of approximately 40,000 individual colonies. To ensure the stability of the mutant, all individual colonies formed in all petri dishes were collected, suspended in a 20% glycerol solution, and then aliquoted into 1.5 mL microtubes of 1 mL each and stored in an ultra-low temperature freezer at -80℃.

[0065] When screening for high-productivity L-alanine mutants, a 20% glycerol suspension taken out of an ultra-low temperature freezer and thawed at room temperature was diluted with saline solution for 10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 -5After serial dilution, 100 ㎕ of the diluted solution corresponding to each dilution factor was spread on the activation medium, and reactivated in the form of individual colonies through culturing in a 30℃ stationary incubator for 24 hours. The reactivated individual colonies were inoculated into a 96 Deep Well Plate, in which 350 ㎕ of the production medium corresponding to a filling rate of 17% was dispensed per well, using the Qpix420 Colony Picker facility of Molecular Devices, and ATCC13869 strain that was not irradiated with gamma rays was inoculated into four wells per plate to serve as a control group for screening high-productivity L-alanine mutants.

[0066] The 96 Deep Well Plates, each inoculated with the control strain and mutant, were sealed using Azenta's Gas permeable seal mark2 and cultured for 48 hours at 30°C and 1,000 rpm in a Multitron shaking incubator from Infors-HT. After 48 hours of culture, the 96 Deep Well Plates were centrifuged for 20 minutes at 15°C and 4,000 rpm in a Centrifuge 5810R from Eppendorf. 100 ㎕ of the culture supernatant from which the cells were separated was transferred to a Corning 96 Well Black Polystyrene Microplate using a Beckman Coulter Liquid handler, Biomek i5, for NIR Spectrometry analysis. Afterwards, the individual analysis spectrum of each well was obtained by applying it to the NIR Spectrometer manufactured in-house by the Analysis & Quality Department of CJ CheilJedang BIO Technology Research Institute, and the regression analysis prediction model with a coefficient of determination of 0.96 for the L-alanine concentration range of 0 to 20 g / L established based on the cultured sample whose L-alanine concentration was quantified through prior HPLC analysis was applied, and the selection logic of an increase in L-alanine concentration by 15% or more compared to the control group was applied, and 64 strains were initially selected out of 10,304 mutant strains. Cultivation was performed in the same way as above for the 64 selected strains, and the top 5 strains with high L-alanine concentrations were finally selected.

[0067] The mutant strains obtained by the above method were named Corynebacterium glutamicum CJ0230, CJ2011, CJ2015, CJ2057, and CJ2064, and were deposited with the Korea Microbiological Conservation Center, an international depository under the Budapest Treaty, on December 19, 2022, and were assigned accession numbers KCCM13305P, KCCM13306P, KCCM13307P, KCCM13308P, and KCCM13309P, respectively.

[0068]

[0069] The composition of the medium used in Examples 1 and 2 is as follows.

[0070] Activation Badge

[0071] Beef extract 5 g / L, polypeptone 10 g / L, yeast extract 5 g / L, urea 2 g / L, sodium chloride (NaCl) 2.5 g / L, agar 20 g / L, glucose 10 g / L, 10N sodium hydroxide (NaOH) 100 ㎕ / L

[0072]

[0073] <Jongbaeji>

[0074] Glucose (anhydrous glucose) 20 g / L, polypeptone 10 g / L, yeast extract 10 g / L, ammonium sulfate [(NH4)2SO4] 10 g / L, urea 1.5 g / L, monobasic potassium phosphate (KH2PO4) 5.2 g / L, dibasic potassium phosphate (K2HPO4) 10.7 g / L, d-Biotin 1.8 mg / L, Thiamine-HCl 9 mg / L, CAPA 9 mg / L, NCA 60 mg / L, Magnesium sulfate (MgSO4) 0.5 g / L

[0075]

[0076] <Production medium>

[0077] Calcium carbonate (CaCO3) 30 g / L, sucrose 57 g / L, BM 6 g / L, magnesium sulfate (MgSO4) 0.5 g / L, (NH4)2SO4 50 g / L, KH2PO4 1 g / L, yeast extract 2 g / L, ammonium acetate 6.28 g / L, d-Biotin 0.05 mg / L, thiamine-HCl 0.1 mg / L, MnSO4 6.7 mg / L, FeSO4 10 mg / L

[0078]

[0079] Example 2. Evaluation of L-alanine productivity of L-alanine producing mutant strains

[0080] In order to confirm the L-alanine productivity of the Corynebacterium glutamicum CJ0230, CJ2011, CJ2015, CJ2057, and CJ2064 strains obtained in Example 1, they were cultured using the following method.

[0081] Specifically, the parent strain Corynebacterium glutamicum ATCC13869 and the five mutant strains were each inoculated into a 250 ml corner-baffle flask containing 25 ml of the seed medium, and then cultured with shaking at 200 rpm at 30°C for 20 hours to obtain a seed culture solution. Thereafter, 1 ml of the seed culture solution was inoculated into a 250 ml corner-baffle flask containing 24 ml of the production medium, and cultured at 200 rpm at 30°C for 72 hours to produce L-alanine. After completion of the culture, the concentration of L-alanine contained in the culture solution was measured using high-performance liquid chromatography (HPLC), thereby determining the L-alanine production amount of each strain. The obtained results are shown in Table 1 below.

[0082] Comparison of L-alanine productivity of Corynebacterium glutamicum strains CJ0230, CJ2011, CJ2015, CJ2057, and CJ2064. ATCC13869 (parent strain) CJ0230 (mutant strain 1) CJ2011 (mutant strain 2) CJ2015 (mutant strain 3) CJ2057 (mutant strain 4) CJ2064 (mutant strain 5) L-alanine concentration (g / l) 6.1 10.7 10.4 9.9 10.1 10.5

[0083] As a result, as shown in Table 1 above, the parent strain Corynebacterium glutamicum ATCC13869 strain produced L-alanine at a concentration of 6.1 g / l. The mutant strains Corynebacterium glutamicum CJ0230 strain, CJ2011 strain, CJ2015 strain, CJ2057 strain, and CJ2064 strain according to the present invention produced L-alanine at concentrations of 10.7 g / l, 10.4 g / l, 9.9 g / l, 10.1 g / l, and 10.5 g / l, respectively, confirming that they had L-alanine productivity of at least about 162% or more compared to the parent strain.

[0084] The above results indicate that the five strains of Corynebacterium glutamicum mutants according to the present invention can produce L-alanine with high efficiency and high yield.

[0085]

[0086] [Accession number]

[0087] Name of depositor: Korea Center for Microbiological Conservation (KCCM)

[0088] Accession number: KCCM13305P

[0089] Date of acceptance: 20221219

[0090]

[0091] Name of depositor: Korea Center for Microbiological Conservation (KCCM)

[0092] Accession number: KCCM13306P

[0093] Date of acceptance: 20221219

[0094]

[0095] Name of depositor: Korea Center for Microbiological Conservation (KCCM)

[0096] Accession number: KCCM13307P

[0097] Date of acceptance: 20221219

[0098]

[0099] Name of depositor: Korea Center for Microbiological Conservation (KCCM)

[0100] Accession number: KCCM13308P

[0101] Date of acceptance: 20221219

[0102]

[0103] Name of depositor: Korea Center for Microbiological Conservation (KCCM)

[0104] Accession number: KCCM13309P

[0105] Date of acceptance: 20221219

[0106]

[0107]

[0108]

[0109]

[0110]

[0111]

Claims

1. A mutant strain of the genus Corynebacterium obtained by mutation of the parent strain, Corynebacterium glutamicum ATCC13869, which has improved L-alanine production ability compared to the parent strain.

2. In the first paragraph, the mutant strain of the genus Corynebacterium is Corynebacterium glutamicum.

3. In the first paragraph, the mutant strain of the genus Corynebacterium is selected from the group consisting of Corynebacterium glutamicum CJ0230 strain (accession number KCCM13305P), Corynebacterium glutamicum CJ2011 strain (accession number KCCM13306P), Corynebacterium glutamicum CJ2015 strain (accession number KCCM13307P), Corynebacterium glutamicum CJ2057 strain (accession number KCCM13308P), and Corynebacterium glutamicum CJ2064 strain (accession number KCCM13309P). A mutant strain of the genus Corynebacterium, which is one of them.

4. A mutant strain of the genus Corynebacterium, wherein the mutation is caused by a method of irradiating with radiation.

5. A mutant strain of the genus Corynebacterium, wherein the radiation is gamma rays in the fourth paragraph.

6. A mutant strain of the genus Corynebacterium, wherein the mutation is caused by irradiation with radiation at a dose of 3.5 kGy to 4.5 kGy per hour in the fourth paragraph.

7. In the first paragraph, the mutant strain is a mutant strain of the genus Corynebacterium, which has an L-alanine production ability that is improved by 1.5 times or more compared to the parent strain, Corynebacterium glutamicum ATCC13869. 8.1) A step of irradiating the parent strain, Corynebacterium glutamicum ATCC13869, to induce mutation; and 2) A method for producing a mutant strain of the genus Corynebacterium having improved L-alanine production ability compared to the parent strain, comprising a step of culturing the mutant strain of step 1) in a medium and selecting a mutant strain having improved L-alanine production ability.

9. A method for producing a mutant strain of the genus Corynebacterium, wherein the radiation is gamma rays in the 8th paragraph.

10. A method for producing a mutant strain of the genus Corynebacterium, wherein the radiation is irradiated at a dose of 3.5 kGy to 4.5 kGy per hour in accordance with paragraph 8.

11. A method for producing a mutant strain of the genus Corynebacterium, wherein the mutant strain of the genus Corynebacterium is Corynebacterium glutamicum.

12. In the 8th paragraph, the mutant strain of the Corynebacterium genus is selected from the group consisting of Corynebacterium glutamicum CJ0230 strain (accession number KCCM13305P), Corynebacterium glutamicum CJ2011 strain (accession number KCCM13306P), Corynebacterium glutamicum CJ2015 strain (accession number KCCM13307P), Corynebacterium glutamicum CJ2057 strain (accession number KCCM13308P), and Corynebacterium glutamicum CJ2064 strain (accession number KCCM13309P). A method for producing a mutant strain of the genus Corynebacterium, which is one of the selected ones.

13. A method for producing a mutant strain of the genus Corynebacterium, wherein the mutant strain has an L-alanine production ability that is 1.5 times or more improved compared to the parent strain, Corynebacterium glutamicum ATCC13869, in the 8th paragraph.

14. A composition for producing L-alanine comprising a mutant strain of Corynebacterium genus of paragraph 1.

15. In the 14th paragraph, the mutant strain of the Corynebacterium genus is selected from the group consisting of Corynebacterium glutamicum CJ0230 strain (accession number KCCM13305P), Corynebacterium glutamicum CJ2011 strain (accession number KCCM13306P), Corynebacterium glutamicum CJ2015 strain (accession number KCCM13307P), Corynebacterium glutamicum CJ2057 strain (accession number KCCM13308P), and Corynebacterium glutamicum CJ2064 strain (accession number KCCM13309P). A composition for producing L-alanine, wherein any one of the following is selected:

16. A method for producing L-alanine, comprising a step of culturing a mutant strain of Corynebacterium genus of paragraph 1 in a medium.

17. In the 16th paragraph, the mutant strain of the Corynebacterium genus is selected from the group consisting of Corynebacterium glutamicum CJ0230 strain (accession number KCCM13305P), Corynebacterium glutamicum CJ2011 strain (accession number KCCM13306P), Corynebacterium glutamicum CJ2015 strain (accession number KCCM13307P), Corynebacterium glutamicum CJ2057 strain (accession number KCCM13308P), and Corynebacterium glutamicum CJ2064 strain (accession number KCCM13309P). A method for producing L-alanine, wherein any one of the following is selected: